Repeated AFP surge: An unusual and potentially misleading tumour marker phenomenon

被引：2

作者：

Al-Karim, HA ^{[1
]}

Bryce, C ^{[1
]}

Mulhall, P ^{[1
]}

Coppin, C ^{[1
]}

机构：

[1] British Columbia Canc Agcy, Tumour Marker Lab, Vancouver, BC V5Z 4E6, Canada

来源：

CLINICAL ONCOLOGY | 2002年 / 14卷 / 04期

关键词：

D O I：

10.1053/clon.2001.0050

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：294 / 295

页数：2

共 6 条

[1]

Carley P. M., 1989, Central Asian Survey, V8, P1, DOI 10.1080/02634938908400679

[2] PROBLEMS OF INTERPRETATION OF SERUM CONCENTRATIONS OF ALPHA-FETOPROTEIN (AFP) IN PATIENTS RECEIVING CYTO-TOXIC CHEMOTHERAPY FOR MALIGNANT GERM-CELL TUMORS [J].

COPPACK, S ;

NEWLANDS, ES ;

DENT, J ;

MITCHELL, H ;

GOKA, G ;

BAGSHAWE, KD .

BRITISH JOURNAL OF CANCER, 1983, 48 (03) :335-340

[3] Serum alpha fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance [J].

de Wit, R ;

Collette, L ;

Sylvester, R ;

de Mulder, PHM ;

Sleijfer, DT ;

Huinink, WWT ;

Kaye, SB ;

van Oosterom, AT ;

Boven, E ;

Stoter, G .

BRITISH JOURNAL OF CANCER, 1998, 78 (10) :1350-1355

[4]

HORWICH A, 1986, CANCER TREAT REP, V70, P1329

[5] Hereditary persistence of α-fetoprotein -: Case report and review of the literature [J].

Schefer, H ;

Mattmann, S ;

Joss, RA .

ANNALS OF ONCOLOGY, 1998, 9 (06) :667-672

[6]

VOGELZANG NJ, 1982, CANCER RES, V42, P4855

← 1 →